BetaSite: Began Phase III trial

InSite Vision Inc. (INSV), Alameda, Calif. Product: BetaSite sustained release eyedrop form of the beta blocker levobunolol Indication: Chronic glaucoma Status: Began Phase III trial in 645 patients,...